Owing to its interaction with alcohol, folate has been suggested to be a potential factor for many types of cancer. The impact of these factors on the risk of breast cancer among Asian populations has not been fully examined, however, particularly with respect to receptor status. We carried out a case-control study in premenopausal and postmenopausal Japanese women, including 1754 breast cancer patients and 3508 noncancer controls. We determined the association between self-reported alcohol drinking, dietary folate intake, and the risk of breast cancer. Odds ratios (ORs) with 95% confidence intervals (CIs) were estimated using logistic models adjusted for potential confounders. Alcohol consumption was associated with the risk of breast cancer, with the OR for a drinker consuming 23 g or more per day relative to a nondrinker of 1.39 (95% CI: 1.07-1.80). A significant inverse association was observed between folate intake and overall risk of breast cancer, with an OR of 0.79 (95% CI: 0.68-0.93; P trend = 0.004) for the highest tertile relative to the lowest. The OR of a drinker consuming 23 g or more per day relative to a nondrinker with a low folate intake was 1.58 (95% CI: 1.06-2.33). However, a significantly increased risk was not observed in tertile 2 and tertile 3 folate in taker with any amount of alcohol consumption. Higher folate intake decreases the risk of breast cancer among Japanese, whereas alcohol intake increases the risk. These two factors interact with each other, and the excess risk of breast cancer with alcohol consumption might be attenuated by increasing the intake of folate. In addition, the effects of folate/alcohol may vary according to the tumor subtype.
Introduction
Epidemiological studies (Zhang et al., 1999; Negri et al., 2000; Rohan et al., 2000; Sellers et al., 2001; Zhang, 2004; Baglietto et al., 2005; Tjønneland et al., 2006; Larsson et al., 2007) suggest that higher folate intake is associated with a lower risk of breast cancer, particularly among women who regularly consume alcohol, which itself increases the risk of breast cancer (Longnecker et al., 1988; IARC, 1988; Singletary and Gapstur, 2001; Hamajima et al., 2002; AICR, 2007; Suzuki et al., 2008a) . Despite extensive research on the association between alcohol intake and breast cancer, conclusive evidence (Nagata et al., 2007; Kawai et al., 2011 ) has yet to be obtained, particularly among Asians, including Japanese; in particular, although many epidemiological studies have examined the interaction between alcohol and folate among Caucasians (Zhang et al., 1999; Sellers et al., 2002; Tjønneland et al., 2006; Maruti et al., 2009) , few studies have done so among Asians (Suzuki et al., 2009; Kawai et al., 2011; Zhang and Holman, 2011) .
Breast cancer is a heterogenous disease and different subtypes are associated with unique risk factors, clinical presentation, prognosis, and treatment response (Carey et al., 2006; Yang et al., 2007) . Many studies have examined alcohol-breast cancer (Suzuki et al., 2008a (Suzuki et al., , 2009 Coronado et al., 2011) and folate-breast cancer (Sellers et al., 2001 (Sellers et al., , 2002 Larsson et al., 2008) associations by estrogen receptor (ER) and progesterone receptor (PR) status, but the results have been inconsistent. Epidemiological studies have evaluated the combined effect of alcohol and folate on breast cancer according to receptor status, but these have been restricted only to Caucasian populations (Sellers et al., 2002; Zhang et al., 2005) .
Several mechanisms to explain alcohol-induced breast cancer have been proposed, including the perturbation of estrogen metabolism and response, mutagenesis by the ethanol metabolite acetaldehyde, and oxidative damage through an effect on one-carbon metabolism pathways through reduced folic acid, and vitamin B intake and use has been considered (Dumitrescu and Shields, 2005; Seitz and Stickel, 2007) . Folate is a vitamin B involved in onecarbon metabolism and participates in nucleotide synthesis and methylation reactions (Dumitrescu and Shields, 2005; Suzuki et al., 2008b) . Alcohol and folate interfere with each other at several points of intestinal absorption, transport, and metabolism. This interaction disrupts folate supply and results in low folate supply to tissues, with a consequent disruption of gene expression and induction of DNA breakage (Shrubsole et al., 2001; Al-Sader et al., 2009) . The risk associated with alcohol consumption might therefore be modified by dietary factors such as folate.
Japanese populations offer a unique means of examining these relationships, as the food supply is not fortified with folic acid and folic acid supplementation is also very low at 0.1% (Imai et al., 2006) . In addition, Japanese women may have etiological factors such as ethnicity, lifestyle, and dietary habits that differ from those in Western countries; for example, the proportion of exogenous hormone use, alcohol consumption, and use of multivitamin supplementation are lower than those in Western countries (Imai et al., 2006; Kawai et al., 2011) . The risk associated with alcohol consumption and its effect modification may therefore be different for Japanese women.
Here, we evaluate the association between alcohol consumption and the risk of breast cancer in Japanese women, particularly whether it is modified by dietary folate intake. We also examined the combined effects of folate and alcohol on the risks of breast cancer. In particular, we aimed to evaluate these items with respect to breast cancer subtype as defined by ER, PR, and human epidermal growth factor receptor 2 (HER2) status.
Participants and methods
Case participants were 1803 female patients with no previous history of cancer who were histologically diagnosed with breast cancer between January 2001 and November 2005 at the Aichi Cancer Center Hospital (ACCH) in Japan. Forty-nine patients whose history of alcohol consumption was unknown were excluded, leaving 1754 cases eligible for analysis. Control participants were 3508 randomly selected female noncancer patients at ACCH whose first visit was during the same period as the case participants who matched for age (±3 years) and menopausal status (before menopause or after menopause) in a 1 : 2 (case : control) ratio. All patients were selected from the database of the Hospital-based Epidemiological Research Program II (HERPACC-II) at ACCH under which (Tajima et al., 2000; Hamajima et al., 2001) all the first-visit outpatients at ACCH aged 20-79 years are asked to fill out a self-administered questionnaire on lifestyle and to provide blood samples. Responses are checked by trained interviewers. Approximately 96.7% of eligible participants complete the questionnaire. We used noncancer patients at our hospital as controls, given the high likelihood that our cases were members of this population. This study was approved by the Ethics Committee of Aichi Cancer Center and written informed consent was obtained from all participants.
Estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2 status ER, PR, and HER2 status were determined following tumor resection by pathologists at ACCH using commercial immunohistochemistry tests and retrieved from medical records. Cases with HER2 results of 0, 1 + , or 2 + from immunohistochemistry testing and/or negative results on fluorescence in-situ hybridization testing greater than 2.2 were considered HER2-negative (HER2 -); conversely, HER2 results of 3 + on immunohistochemistry testing were considered HER2-positive (HER2 +). Of 1754 case participants, data on ER, PR, and HER2 status were available for 1093, 1084, and 702, respectively. Of the 1093 tumors with known ER status, 527 were premenopausal and 564 were postmenopausal patients. Among the premenopausal patients, 420 (79.7%) tumors were ER + and 107 (20.3%) were ER -, whereas for the postmenopausal patients, 385 (68.3%) were ER + and 179 (31.7%) were ER -. Information on the status of all three receptors was available for only 702 patients, of whom 335 were premenopausal and 366 were postmenopausal.
Assessment of alcohol, folate, and other lifestyle factors
Information on all relevant factors in this study was collected using a self-administered questionnaire. The reference time for control participants was the time the participant answered the questionnaire, and that for case patients was the period before the patient first presented with symptoms or the event that led them to visit ACCH. Daily alcohol consumption in grams was determined by summing the pure alcohol amount in the average daily consumption of Japanese sake (rice wine), shochu (distilled spirit), beer, wine, and whiskey, with 1 cup of Japanese sake (180 ml) considered equivalent to 23 g of ethanol, one drink of shochu (108 ml) to 23 g, one large bottle of beer (633 ml) to 23 g, one glass of wine (80 ml) to 10 g, and one shot of whiskey (28.5 ml) to 11.5 g. We estimated daily ethanol consumption as a product of the frequency of alcohol consumption and the average amount of ethanol consumed on each occasion. Drinking habit was classified into four categories: nondrinker, 1 to <5, 5 to <23, and Z 23 g/day. The daily intake of folate was determined using a food frequency questionnaire (FFQ), described in detail elsewhere (Tokudome and Imaeda, 2005; Imaeda et al., 2007) . Folate consumption from supplements could not be considered in total consumption because the questionnaire for multivitamins was not quantitative. The main contributors toward folate intake among Japanese are dietary source such as vegetables, fruits, milk, liver, beans, etc. Energy-adjusted intake of folate was calculated using the residual method (Willett, 1986) . The FFQ was validated using a 3-day weighed dietary record as the standard, which showed that reproducibility and validity were satisfactory (Tokudome and Imaeda, 2005; Imaeda et al., 2007) . The deattenuated correlation coefficient for energy-adjusted intakes of folate in women was 0.38 [95% confidence interval (CI): 0.25-0.59] (Tokudome and Imaeda, 2005) . We applied categorization by tertile on the basis of threshold values in the controls.
Smoking habit was classified into five categories: never, 1 to <15, 15-30, 30-45, and >45 pack-years. Pack-years represent the cumulative amount of smoking, and are calculated as the product of the number of packs consumed per day and the number of years of smoking. BMI was calculated as weight divided by the squared height (kg/m 2 ) and was self-reported during the first hospital visit at the outpatient clinic. Participants were asked about the frequency and intensity of recreational exercise. The average daily exercise of any intensity was calculated and categorized as none, <0.5, and >0.5 h/day. Age at menarche was categorized as r 12, 13-14, and Z 15 years; parity as 0 or no baby, 1-2 children, and Z 3 children. Patients were considered to have a family history of breast cancer if their mother or sister had breast cancer.
Statistical analysis
To determined the strength of associations between alcohol intake and the risk of breast cancer, odds ratios (ORs) with 95% CIs were estimated using conditional logistic models adjusted for potential confounders, except subgroup analyses by receptor status, which were estimated using a multinomial logistic model. Potential confounders considered in the multivariate analyses were age, smoking habit, BMI, drinking habit, daily physical activity of any intensity, family history of breast cancer, total energy intake (as a continuous variable), age at menarche, parity, and referral pattern to our hospital. Missing values for each variable were assigned as dummy variables. To account for differences in background medical conditions between cases and controls, we adjusted for referral pattern to our hospital. Differences in the categorized demographic variables between cases and controls were tested using the w 2 -test. The mean values for age and the total energy intake between cases and controls were compared using Student's t-test. The interaction between alcohol and intake of folate was evaluated under the multiplicative assumption. The cross-product of scores for alcohol (nondrinker, 1 r 5, 5 r 23, Z 23 g ethanol/day) and folate intake (1, tertile 1; 2, tertile 2; and 3, tertile 3) was included as an interaction term in the models. The likelihood ratio test is used to calculate the interaction term in the model. We compared the model with and without the interaction term. We used multinomial logistic regression to compare the ER + , and ER -, case group with a common control group and ER + and/or PR + /HER2 + , ER + and/or PR + /HER2 -, ER -PR -/HER2 + , and ER -/PR -/ HER2 -, case group with a common control group; this approach is directly comparable with the use of a series of binary logistic regression models for different casecontrol comparisons (Begg Colin, 1984) . As the basis for the trend test, folate intake and alcohol consumption was categorized with scores of 0, 1, 2 and 0, 1, 2, 3, respectively. Values were considered statistically significant when the P-value was less than 0.05. All analyses were carried out using STATA, version 10.1 (Stata, College Station, Texas, USA).
Results
The background characteristics of all the patients are shown in Table 1 . Age was appropriately matched.
Smoking habits did not significantly differ between the two groups. In contrast, the proportions of patients with a high BMI (P < 0.001), low daily physical activity (P = 0.014), and a family history of breast cancer (P = 0.025) were significantly higher among cases than controls. With respect to referral patterns, friend or family recommendations and referrals from other clinics were more frequent among cases than controls.
Intake of alcohol was associated positively with the risk of breast cancer (Table 2 ). The OR for drinkers who drink at least 23 g/day compared with nondrinkers was 1.39 (95% CI: 1.07-1.80; P trend = 0.002). In stratified analysis by menopausal status, a stronger association with alcohol intake was observed among postmenopausal women, with an OR of 1.69 (95% CI: 1.14-2.51; P trend = 0.001) for women who drank at least 23 g/day relative to nondrinkers. In contrast, no significant positive association was observed among premenopausal women. Folate intake was associated inversely with the risk of breast cancer. High folate intake was associated significantly with a lower risk of developing overall and premenopausal breast cancer. ORs and 95% CI comparing the highest versus the lowest tertile of folate intake were 0.79 (95% CI: 0.68-0.93; P trend = 0.004) for overall and 0.62 (95% CI: 0.49-0.79; P trend < 0.001) for premenopausal breast cancer. No significant inverse association with folate was observed among postmenopausal women. Table 3 shows an analysis of the interaction between alcohol and folate intake. We observed a significant interaction between alcohol and folate intake among postmenopausal women (P interaction = 0.003), whereas no obvious interaction was found among premenopausal women (P interaction = 0.841).
Associations between alcohol intake and the risk of breast cancer stratified by tumor receptor status are shown in Table 4 . Among premenopausal women, the impact of alcohol on the risk of breast cancer was not obvious across all subtypes. Among postmenopausal women, in contrast, ORs for drinking at least 23 g alcohol/day relative to nondrinkers were higher than unity for most subtypes and showed a statistically significant association for ER -PR -/HER2 + (OR = 2.99, 95% CI: 1.08-8.26) and ER -/ PR -/HER2 -(OR = 3.72, 95% CI: 1.30-10.67). Table 5 shows the effect of folate intake on breast cancer according to tumor receptor status. Among premenopausal women, ORs for the highest versus the lowest tertile of folate intake were inversely associated with the risk of most breast cancer subtypes and showed a statistically significant association with ER + and/or PR + /HER2 -(OR = 0.51, 95% CI: 0.34-0.75), ER + (OR = 0.61, 95% CI: 0.45-0.83), and ER -(OR = 0.54, 95% CI: 0.30-0.96) tumor subtypes. Among postmenopausal women, in contrast, no protective effect of folate was obvious across all subtypes, except ER -/PR -/HER2 -(OR = 0.44, 95% CI: 0.20-0.96), for which the association was statistically significant.
We further examined the combined effects of folate and alcohol on the risk of breast cancer stratified by receptor status (Table 6 ). To improve the stability of the statistical calculation, the number of folate intake categories was decreased from three to two [tertile 1 as the low group (130.9-278.5 mg/day) and tertile 2 and tertile 3 as the high group (278.5-1287.5 mg/day)], whereas the categories of alcohol consumption were decreased from four to two (< 5 and Z 5 g alcohol/day). Among premenopausal women, the risk of ER + , ER + and/or PR + /HER2and ER -/PR -/HER2 + breast cancer with low folate and at least 5 g alcohol/day compared with high folate and less than 5 g alcohol/day ORs was 1.48 (95% CI: 1.01-2.19), 1.77 (95% CI: 1.09-2.86), and 4.40 (95% CI: 1.30-14.81), respectively. In contrast, the risk was increased among postmenopausal women with low folate and at least 5 g alcohol/day compared with high folate and less than 5 g alcohol/day, with ORs of 1.58 (95% CI: 1.20-2.09) and 3.67 (95% CI: 1.29-10.39) among ER + and ER -/PR -/HER2 -tumor subtypes, respectively.
Discussion
In this case-control study among Japanese women, we found that alcohol consumption was associated positively with the overall risk of breast cancer, and that this effect was modified by folate intake. Further folate intake was associated inversely with the risk of overall breast cancer. These results varied appreciably by menopausal status; specifically, alcohol consumption increased the risk for postmenopausal women and folate intake was protective among premenopausal women. In premenopausal women who consumed at least 5 g alcohol/day with low folate, the risk of ER + , ER + and/or PR + /HER2 -, and ER -/ PR -/HER2 + breast cancer was significantly increased compared with those with a high folate intake. Among postmenopausal women, the risk of ER -/PR -/HER2breast cancer associated with alcohol consumption appeared to be reduced by a high intake of folate.
Epidemiological studies of folate and breast cancer have yielded inconsistent results (Zhang et al., 2005; Larsson et al., 2008; Maruti et al., 2009; Roswall et al., 2010; Stevens et al., 2010) . Several studies have indicated that high dietary folate intake or adequate circulating levels of folate might reduce the risk of breast cancer, particularly among women with higher alcohol intake (Zhang et al., 1999 (Zhang et al., , 2004 Sellers et al., 2001; Tjønneland et al., 2006) ; this interaction was more apparent when studies examined the combined effects of folate and alcohol. In agreement with our present results, many studies (Zhang et al., 1999; Sellers et al., 2001; Lajous et al., 2006; Tjønneland et al., 2006; Larsson et al., 2007; Maruti et al., 2009) suggest that adequate dietary folate intake can reduce the excess risk of breast cancer associated with alcohol consumption. Inconsistent with our findings, however, most studies (Sellers et al., 2002; Maruti et al., 2009; Shrubsole et al., 2011) suggest that folate intake is particularly protective for either ER -or ER + breast cancer and that the alcohol-breast cancer association is limited to ER + , ER -, or ER + /PR + premenopausal/ postmenopausal breast cancer subtypes (Enger et al., 1999; Suzuki et al., 2005) . Our study suggests that folate and alcohol are not only associated with ER/PR-related breast cancer but also with the ER + and/or PR + / HER2 -, ER -/PR -/HER2 + , and ER -/PR -/HRE2subtypes. This inconsistency might be because of the influence of age, race, diet, reproductive, and genetic and environmental factors or to the inclusion of the HER2 tumor marker.
Few studies (Sellers et al., 2002; Zhang et al., 2005; Larsson et al., 2008) have evaluated how alcohol-related and folate-related risk varies by receptor-defined breast cancer. Alcohol is a known folate antagonist and is considered to increase the risk of breast cancer partly by influencing the absorption and metabolism of folate and interfering with one-carbon metabolism (Hillman and Steinberg, 1982; Weir et al., 1985; Suzuki et al., 2008b; Maruti et al., 2009) . A low folate status may impair DNA repair synthesis and alter DNA methylation and thereby adversely influence gene expression and DNA integrity and stability (Kim, 2004) and lead to protooncogene activation (Duthie, 1999; Dumitrescu and Shields, 2005; Suzuki et al., 2008b) . Emerging data suggest that alcohol may stimulate ER, epidermal growth factor receptor, and Her2/neu signaling, which may contribute toward breast cancer genesis and HER2 mammary tumor development (Mill et al., 2009; Wong et al., 2011) .
Several methodological strengths and limitations of this study warrant mention. One strength is the relatively large sample size, particularly considering the lower incidence of breast cancer in Asian than Western countries, and detailed information on three receptors including the HER2 receptor. To our knowledge, this study is the first to examine the association between alcohol and dietary folate intake by molecular subtype of breast cancer, including the HER2 receptor. Second, the potential effect of confounding was considered by matching age, menopausal status, and by statistical adjustment, although the effect of residual confounding could not be completely ruled out.
Our study is limited by the fact that dietary intake was assessed by self-administered FFQ, which will inevitably lead to some error in the measurement of folate intake. Nevertheless, the validity and reproducibility of the FFQ was satisfactory (Tokudome and Imaeda, 2005; Imaeda et al., 2007) , and fortification of food with folic acid (synthetic form of folate) is not mandated in Japan as it is in the USA and other Western countries. Further folic Table 3 Interaction between alcohol and folate intake for the risk of breast cancer acid supplementation is very low (0.1%) (Imai et al., 2006) even among pregnant women, which indicates that our analysis is not influenced by fortification or supplementation. Second, like other case-control studies, the possibility of recall bias was present; to minimize this, questionnaires were completed before diagnosis at our hospital. Third, the selection of controls from noncancer patients at the hospital might also be problematic. However, as cases and controls were selected from the same hospital and almost all patients (97%) lived in the Aichi area of central Japan (Inoue et al., 1997) , controls might be representative of the case population.
Conclusion
Our study indicates that alcohol consumption increased the risk of breast cancer in a Japanese population and that dietary folate intake is protective for it. Further, the impact of alcohol on breast cancer was modified by ORs from multinomial logistic regression models adjusted for age, folate intake, smoking habit, BMI, daily physical activity of any intensity, family history of breast cancer in a first-degree relative, menopausal status, age at menarche, parity, and total nonalcohol energy, and referral pattern to our hospitals. CI, confidence interval; OR, odds ratio. ORs from multinomial logistic regression models adjusted for age, drinking habit, smoking habit, BMI, daily physical activity of any intensity, family history of breast cancer in a first-degree relative, menopausal status, age at menarche, parity, and total nonalcohol energy, and referral pattern to our hospitals. t1, tertile 1 (lowest); t2, tertile 2 (middle); t3, tertile 3 (highest). CI, confidence interval; OR, odds ratio.
dietary folate intake and menopausal status. Also, alcohol and folate may have different influences on breast cancer receptor-defined subtype depending on menopausal status. Our findings also support the hypothesis that the excess risk of breast cancer associated with alcohol consumption may be reduced by adequate folate intake. A conclusive understanding of the differences in the association of alcohol consumption and the alcohol-folate association by specific subtypes of breast cancer awaits further research in a larger population.
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